COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma

Figure 2

Correlations between COX7B expression in ESCA and clinical variables. (a) The distinct upregulation of COX7B was observed in ESCA specimens compared with nontumor specimens based on TCGA datasets. (b–g) Clinical features of ESCA and COX7B mRNA expression.

(a)

(b)

(c)

(d)

(e)

(f)

(g)